Earnings Outlook For ImmunoPrecise Antibodies
Portfolio Pulse from Benzinga Insights
ImmunoPrecise Antibodies (NASDAQ:IPA) is scheduled to release its quarterly earnings report on March 14, 2024, with an estimated EPS of $-0.07. The company's past earnings performance shows a pattern of beating EPS estimates but experiencing subsequent share price drops. Over the last 52 weeks, IPA shares have declined by 50.45%, indicating negative sentiment among long-term shareholders.
March 13, 2024 | 7:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ImmunoPrecise Antibodies is expected to report an EPS of $-0.07 for the upcoming quarter. Historical data shows that despite beating EPS estimates, the stock price has tended to drop following earnings announcements.
Given the historical pattern of stock price declines following earnings beats and the overall 50.45% decrease in share price over the last year, it's likely that the upcoming earnings report could lead to a short-term negative impact on IPA's stock price. This is despite the company potentially beating the EPS estimate, as past performance has shown that positive earnings results have not translated into positive stock price movements.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100